Drew M. Pardoll

DREW M. PARDOLL, A&S 1976, Med 1982 (MD/PhD), the Martin D. Abeloff Professor, was among the first researchers to develop genetically engineered cancer vaccines, a number of which are in advanced clinical testing. His current research focuses on understanding the molecular basis of lymphocyte recognition and using this knowledge to study the cellular basis of immune function, focusing predominantly on T cells. He holds appointments in the departments of Oncology, Medicine, Molecular Biology and Genetics, and Pathology. He also directs the Division of Immunology in the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. Pardoll has taught at Hopkins since 1988. He holds numerous patents and he has published more than 100 journal articles. In early 2016, Dr. Pardoll was appointed Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy.